Your text here

Chart test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec a gravida nulla. Suspendisse volutpat commodo dignissim. Praesent fringilla sit amet lectus sed vestibulum.

AlloSeq cfDNA at varying levels provides meaningful, actionable information to your existing clinical paradigm. Distribution of AlloSure dd-cdDNA scores from over 7,000 patient samples with varying decision support levels. At 2.9%, 94% specificity for ABMR in DSA positive patients. 1%, threshold for active rejection. 5% threshold for TMCR/borderline differentiation. At .21%, 95% NPV for active rejection.

Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec a gravida nulla. Suspendisse volutpat commodo dignissim. Praesent fringilla sit amet lectus sed vestibulum.

AlloSeq cfDNA at varying levels provides meaningful, actionable information to your existing clinical paradigm. Distribution of AlloSure dd-cdDNA scores from over 7,000 patient samples with varying decision support levels. At 2.9%, 94% specificity for ABMR in DSA positive patients. 1%, threshold for active rejection. 5% threshold for TMCR/borderline differentiation. At .21%, 95% NPV for active rejection.